Towards Quantitation of the Effects of Renal Impairment and Probenecid Inhibition on Kidney Uptake and Efflux Transporters, Using Physiologically Based Pharmacokinetic Modelling and Simulations by Hsu Vicky, de L T Vieira Manuela, Zhao Ping, Zhang Lei, Zheng Jenny Huimin, Nordmark Anna, Berglund Eva Gil, Giacomini Kathleen M, Huang Shiew-Mei in Clinical pharmacokinetics (2013).

[PMID: 24214317] PubMed


The kidney is a major drug-eliminating organ. Renal impairment or concomitant use of transporter inhibitors may decrease active secretion and increase exposure to a drug that is a substrate of kidney secretory transporters. However, prediction of the effects of patient factors on kidney transporters remains challenging because of the multiplicity of transporters and the lack of understanding of their abundance and specificity. The objective of this study was to use physiologically based pharmacokinetic (PBPK) modelling to evaluate the effects of patient factors on kidney transporters.

[ hide abstract ]

Discussed In Paper


Rx Annotations

No dosing information annotated.